Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1987 1
1988 1
2002 1
2003 2
2004 1
2005 1
2007 2
2008 1
2009 1
2010 1
2011 1
2012 2
2015 3
2016 2
2017 1
2018 3
2019 2
2020 1
2021 14
2022 23
2023 14
2024 19
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Rischin D, Porceddu S, Day F, Brungs DP, Christie H, Jackson JE, Stein BN, Su YB, Ladwa R, Adams G, Bowyer SE, Otty Z, Yamazaki N, Bossi P, Challapalli A, Hauschild A, Lim AM, Patel VA, Walker JL, De Liz Vassen Schurmann M, Queirolo P, Cañueto J, Ferreira da Silva FA, Stratigos A, Guminski A, Lin C, Damian F, Flatz L, Taylor AE, Carr DR, Harris S, Kirtbaya D, Quereux G, Rutkowski P, Basset-Seguin N, Khushalani NI, Robert C, Ju H, Joseph C, Bansal S, Chen CI, Seebach F, Yoo SY, Lowy I, Goncalves P, Fury MG; C-POST Trial Investigators. Rischin D, et al. Among authors: carr dr. N Engl J Med. 2025 Aug 21;393(8):774-785. doi: 10.1056/NEJMoa2502449. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454639 Clinical Trial.
Identifying critical quality metrics in Mohs Surgery: A national expert consensus process.
Dodson JA, Ibrahim SA, Rogers H, Council ML, Nehal KS, Tung R, Leffell DJ, Zeitouni NC, Totonchy MB, Fosko SW, Lee Soon S, Blalock TW, Brodland DG, Billingsley EM, Scott JF, Leach BC, Ratner D, Washington C, Hanke CW, Otley CC, Golda N, Nijhawan RI, Brewer J, Demer A, Fish F, Harmon CB, Zitelli J, Knackstedt T, Singh G, Mollet T, Carr DR, Albertini JG, Moody BR, McDonald M, Bordeaux JS, Massey PR, MacCormack MA, Vidimos A, Arpey CJ, Arron ST, Ibrahimi OA, Jiang SB, Miller CJ, Maher IA, Wysong A, Leshin B, Goldman GD, Kibbi N, Feng H, Collins L. Dodson JA, et al. Among authors: carr dr. J Am Acad Dermatol. 2024 Apr;90(4):798-805. doi: 10.1016/j.jaad.2023.10.069. Epub 2023 Dec 9. J Am Acad Dermatol. 2024. PMID: 38081390
Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study.
Granger EE, Ran NA, Groover MK, Koyfman SA, Vidimos AT, Wysong A, Carr DR, Shahwan KT, Hirotsu KE, Carucci JA, Carter JB, Cañueto J, Girardi FM, Mangold AR, Srivastava D, Brodland DG, Zitelli JA, Willenbrink TJ, Ruiz ES. Granger EE, et al. Among authors: carr dr. J Am Acad Dermatol. 2024 Nov;91(5):957-960. doi: 10.1016/j.jaad.2024.06.072. Epub 2024 Jul 4. J Am Acad Dermatol. 2024. PMID: 38971189 No abstract available.
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study.
Curtis KK, Fakult NJ, Strunck JL, Aasi SZ, Ahn CS, Alam M, Bar AA, Behshad R, Bichakjian CK, Bolotin D, Boone SL, Bordeaux JS, Brewer JD, Carr DR, Carucci JA, Castillo JR, Christensen SR, Clark MA, Collins LK, Demer AM, Eisen DB, Feng H, Firoz BF, Grekin RC, Hirshburg JM, Holmes TE, Huang CC, Jennings TA, Jiang SIB, Konda S, Leitenberger JJ, Lewin JM, Maher IA, Ng E, Orengo IF, Samie FH, Saylor DK, Sharon VR, Soleymani T, Swetter SM, Tate JA, Van Beek MJ, Vidal NY, Vij A, Wysong A, Xu YG, Carroll BT, Yu WY. Curtis KK, et al. Among authors: carr dr. J Natl Compr Canc Netw. 2024 Jul 30;22(8):e247036. doi: 10.6004/jnccn.2024.7036. J Natl Compr Canc Netw. 2024. PMID: 39079545
Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: A real-world single-center retrospective review.
Patel S, Armbruster H, Pardo G, Archambeau B, Kim NH, Jeter J, Wu R, Kendra K, Contreras CM, Spaccarelli N, Dulmage B, Pootrakul L, Carr DR, Verschraegen C. Patel S, et al. Among authors: carr dr. PLoS One. 2024 Apr 30;19(4):e0297531. doi: 10.1371/journal.pone.0297531. eCollection 2024. PLoS One. 2024. PMID: 38687774 Free PMC article.
Metastatic Spiradenocarcinoma Managed With PD-1 Inhibition.
Wargo JJ, Carr DR, Plaza JA, Verschraegen CF. Wargo JJ, et al. Among authors: carr dr. J Natl Compr Canc Netw. 2022 Feb 23:1-3. doi: 10.6004/jnccn.2021.7119. Online ahead of print. J Natl Compr Canc Netw. 2022. PMID: 35196645
Off-label uses of rituximab in dermatology.
Carr DR, Heffernan MP. Carr DR, et al. Dermatol Ther. 2007 Jul-Aug;20(4):277-87. doi: 10.1111/j.1529-8019.2007.00141.x. Dermatol Ther. 2007. PMID: 17970893 Review.
A multicenter validation study of Mohs micrographic surgery versus wide local excision in primary high-stage cutaneous squamous cell carcinoma.
Wang DM, Ran NA, Granger EE, Koyfman S, Vidimos A, Wysong A, Carr DR, Shahwan KT, Hirotsu KE, Carucci JA, Carter JB, Cañueto J, Girardi FM, Mangold AR, Srivastava D, Nijhawan RI, Brodland DG, Zitelli JA, Willenbrink TJ, Ruiz ES. Wang DM, et al. Among authors: carr dr. J Am Acad Dermatol. 2025 Aug;93(2):527-532. doi: 10.1016/j.jaad.2025.04.010. Epub 2025 Apr 8. J Am Acad Dermatol. 2025. PMID: 40210096 No abstract available.
101 results